Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
NIH Requests Public Input on Genetic Testing Registry, Indicates Intent to Include DTC Firms
June 02, 2010
In a request for public input on the scope of its planned voluntary genetic testing registry, NIH indicates that it "anticipates" including tests from direct-to-consumer genomics firms.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- PGen Study to Survey 1K Subjects to Investigate Impact of Personal Genomics Data
March 7, 2012 / Pharmacogenomics Reporter - NIH Study Finds DTC Genetic Risk Info Doesn't Increase Patients' Use of Healthcare Services
May 23, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - American Bar Association Passes Resolution on DTC Marketing of Genetic Tests
August 24, 2011 / Pharmacogenomics Reporter - DTC Genomics Firms Say They Want to Comply with FDA Regs but Maintain Direct Access
March 16, 2011 / Pharmacogenomics Reporter